This inventor holds 3 USPTO granted patents. Top assignee: Armour Pharmaceutical Company. Active years: 1984-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1988
Title: The Innovations of Ricardo H. Landaburu
Introduction
Ricardo H. Landaburu is a notable inventor based in Rye, NY (US). He has made significant contributions to the field of biochemistry, particularly in the purification and pasteurization of plasma proteins. With a total of 3 patents to his name, Landaburu's work has had a substantial impact on medical and pharmaceutical applications.
Latest Patents
One of his latest patents is a method of purifying Factor VIII:C. This process involves adsorbing Factor VIII:C onto a hydrophobic interaction matrix, separating unwanted proteins, and eluting Factor VIII:C using a solution containing a surface active agent. Another significant patent is for a process for pasteurizing fibronectin. This innovative method heats and simultaneously agitates a plasma protein solution in the presence of a polyol, a surface active agent, and a chelating agent, effectively inactivating viruses while preserving the protein's physical and biological properties.
Career Highlights
Ricardo H. Landaburu is currently associated with Armour Pharmaceutical Company, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the safety and efficacy of plasma-derived therapies.
Collaborations
Throughout his career, Landaburu has collaborated with esteemed colleagues, including David L. Farb and Robert H. Yue. These partnerships have fostered innovation and contributed to the success of his projects.
Conclusion
Ricardo H. Landaburu's contributions to the field of biochemistry through his patents and collaborations highlight his dedication to improving medical therapies. His innovative methods for purifying and pasteurizing plasma proteins are vital advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile